Skip to main content

A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2

Clinical Trial Grant
Duke Scholars

Administered By

Duke Human Vaccine Institute

Awarded By

Pfizer, Inc.

Start Date

June 9, 2021

End Date

June 8, 2023
 

Administered By

Duke Human Vaccine Institute

Awarded By

Pfizer, Inc.

Start Date

June 9, 2021

End Date

June 8, 2023